GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
D000470:Alkaloids / Q000494:pharmacology; D000613:Aminobutyrates / Q000037:antagonists & inhibitors*; D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D003913:Dextroamphetamine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004149:Dioxoles / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004558:Electric Stimulation; D004569:Electroencephalography; D018756:GABA Antagonists; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D007546:Isoquinolines / Q000494:pharmacology; D008032:Limbic System / Q000502:physiology; D008688:Methacholine Compounds / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D012559:Schizophrenia / Q000503:physiopathology*; D012653:Self Stimulation; D013238:Stereotaxic Techniques; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology; D013681:Tegmentum Mesencephali / Q000502:physiology
D000470:Alkaloids; D000613:Aminobutyrates; D000639:Amitriptyline; D001285:Atropine; D003913:Dextroamphetamine; D004295:Dihydroxyphenylalanine; D004149:Dioxoles; D004298:Dopamine; D018756:GABA Antagonists; D006220:Haloperidol; D006892:Hydroxydopamines; D007546:Isoquinolines; D008688:Methacholine Compounds; D010852:Picrotoxin